SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kraig Biocraft Laboratories, Inc – ‘S-1’ on 10/2/09 – EX-3.2

On:  Friday, 10/2/09, at 4:59pm ET   ·   Accession #:  1213900-9-2710   ·   File #:  333-162316

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 12/16/09   ·   Latest:  ‘S-1/A’ on 11/22/23   ·   41 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/02/09  Kraig Biocraft Laboratories, Inc  S-1                    4:2.3M                                   Edgar Agents LLC/FA

Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement                              HTML   1.29M 
 2: EX-3.2      Articles of Amendment                               HTML      9K 
 3: EX-10.4     Amended Letter Agreement, Dated September 14,       HTML     32K 
                          2009, by and Between Kraig Biocraft                    
                          Laboratories and Calm Seas Capital, LLC                
 4: EX-23.1     Consent of Webb & Company, P.A.                     HTML      7K 


EX-3.2   —   Articles of Amendment


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 
Max Maxfield, WY Secretary of State
FILED: 03/18/2009 02:38 PM
Original ID:2006-000513138
Amendment ID: 2009-000744029
 
 
 

 
PROFIT CORPORATION
 
ARTICLES OF AMENDMENT BY BOARD OF DIRECTORS
 
1. The name of the corporation is KRAIG BIOCRAFT LABORATORIES, INC.
 
2. Article III is amended as follows:
 
The number and class of shares the company is authorized to issue are:
Unlimited shares Class A common stock at no par value
Unlimited shares of Class B common stock (no voting rights) at no par value
Unlimited shares of Preferred stock at no par value
 
3. Article IV is amended as follows:
 
The number and class of shares that are entitled to receive the net assets upon dissolution are:
Unlimited share of Class A common stock at no par value
Unlimited snares of Class B common stock (no voting rights) at no par value
Unlimited shares of Preferred stock at no par value
 
4. The date of the adoption of the above amendments is February 16, 2009.
 
5. The amendments were adopted by at least two-thirds of the board of directors without shareholder action and shareholder action was not required.
 
 
Date: 02/17/2009
 
 /s/ Kim Thompson
Kim Thompson
CEO

Contact: Kim Thompson
Daytime phone: 517-336-080

Dates Referenced Herein

This ‘S-1’ Filing    Date    Other Filings
Filed on:10/2/09None on these Dates
2/16/09
 List all Filings 


41 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  Kraig Biocraft Laboratories, Inc. 10-K       12/31/23   75:8.1M                                   M2 Compliance LLC/FA
11/22/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
11/16/23  Kraig Biocraft Laboratories, Inc. 424B3                  1:878K                                   M2 Compliance LLC/FA
11/13/23  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/23   66:7.4M                                   M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. POS AM                67:13M                                    M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
 8/14/23  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/23   66:7.4M                                   M2 Compliance LLC/FA
 6/06/23  Kraig Biocraft Laboratories, Inc. S-1/A                 66:13M                                    M2 Compliance LLC/FA
 5/18/23  Kraig Biocraft Laboratories, Inc. 424B3                  1:739K                                   M2 Compliance LLC/FA
 5/12/23  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/23   65:7.3M                                   M2 Compliance LLC/FA
 5/09/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/27/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.9M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. POS AM                65:9.1M                                   M2 Compliance LLC/FA
 3/29/23  Kraig Biocraft Laboratories, Inc. 10-K       12/31/22   70:8.7M                                   M2 Compliance LLC/FA
12/01/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:14M                                    M2 Compliance LLC/FA
11/17/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:1.1M                                   M2 Compliance LLC/FA
11/14/22  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/22   64:7.2M                                   M2 Compliance LLC/FA
 8/12/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:858K                                   M2 Compliance LLC/FA
 8/01/22  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/22   63:6.8M                                   M2 Compliance LLC/FA
 5/25/22  Kraig Biocraft Laboratories, Inc. S-1/A                 64:12M                                    M2 Compliance LLC/FA
 5/10/22  Kraig Biocraft Laboratories, Inc. 424B3                  1:736K                                   M2 Compliance LLC/FA
 5/06/22  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/22   64:6.3M                                   M2 Compliance LLC/FA
 4/14/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:10M                                    M2 Compliance LLC/FA
 3/23/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.7M                                   M2 Compliance LLC/FA
 3/16/22  Kraig Biocraft Laboratories, Inc. 10-K       12/31/21   69:9.6M                                   M2 Compliance LLC/FA
 2/10/22  Kraig Biocraft Laboratories, Inc. S-1                   67:13M                                    M2 Compliance LLC/FA
12/03/21  Kraig Biocraft Laboratories, Inc. S-1/A                 64:13M                                    M2 Compliance LLC/FA
11/05/21  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/21   64:7.3M                                   M2 Compliance LLC/FA
 8/25/21  Kraig Biocraft Laboratories, Inc. S-1/A                 63:12M                                    M2 Compliance LLC/FA
 8/12/21  Kraig Biocraft Laboratories, Inc. 10-Q        6/30/21   63:6.5M                                   M2 Compliance LLC/FA
 5/26/21  Kraig Biocraft Laboratories, Inc. S-1/A                 86:9.3M                                   M2 Compliance LLC/FA
 5/10/21  Kraig Biocraft Laboratories, Inc. 10-Q        3/31/21   62:4.3M                                   M2 Compliance LLC/FA
 4/05/21  Kraig Biocraft Laboratories, Inc. S-1                   63:6M                                     M2 Compliance LLC/FA
 3/12/21  Kraig Biocraft Laboratories, Inc. 10-K       12/31/20   67:5.7M                                   M2 Compliance LLC/FA
 2/18/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
 2/08/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
12/11/20  Kraig Biocraft Laboratories, Inc. 8-A12G                 2:546K                                   M2 Compliance LLC/FA
11/10/20  Kraig Biocraft Laboratories, Inc. 10-Q        9/30/20   57:4.8M                                   M2 Compliance LLC/FA
 8/24/20  Kraig Biocraft Laboratories, Inc. S-1/A                 68:7.8M                                   M2 Compliance LLC/FA
10/29/09  SEC                               UPLOAD9/22/17    1:68K  Kraig Biocraft Laboratories, Inc.
Top
Filing Submission 0001213900-09-002710   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 4:28:20.3am ET